Description

▪ Introduction

Drostanate 100 mg by Novotex Pharma contains Drostanolone Propionate, a fast-acting injectable anabolic-androgenic compound historically studied in medical research for its anti-estrogenic properties, particularly in certain breast cancer cases. In laboratory environments, it is explored for its anabolic potential, lean tissue preservation, and influence on metabolic pathways.

Produced under strict pharmaceutical-grade manufacturing standards, each ampoule provides a consistent 100 mg/mL concentration. Packaged in 10 × 1 mL sterile glass ampoules, Drostanate is intended exclusively for laboratory and analytical use.

▪ Product Details

• Active Ingredient: Drostanolone Propionate

• Dosage Strength: 100 mg/mL

• Form: Injectable solution (intramuscular)

• Brand: Novotex Pharma

• Package Size: 10 × 1 mL ampoules

• Intended Use: Laboratory and analytical use

▪ Pharmacokinetics

Drostanolone Propionate has a short half-life of approximately 2–3 days due to its propionate ester. This requires administration every 2–3 days in research protocols to maintain stable experimental plasma levels. It supports rapid-action studies on androgenic modulation, lean mass regulation, and non-estrogenic anabolic signaling.

▪ Usage Recommendations

• Typical Experimental Dosage: 50–100 mg every 2–3 days

• Administration Route: Intramuscular injection (aseptic technique required)

• Use Statement: Strictly for laboratory and analytical use only

▪ Disclaimer

This product is strictly intended for laboratory research and analytical use. Not approved for human consumption or medical application. Not suitable for individuals under 18, pregnant or breastfeeding women, or those with any health conditions. All handling must follow institutional protocols and local regulations.